唐雯 , 郭红霞 . 新型腹膜透析液的研究进展[J]. 中国血液净化, 2020 , 19(06) : 403 -405 . DOI: 10.3969/j.issn.1671-4091.2020.06.011

1. Nakayama M, Watanabe K, Hayashi Y, et al. Translational Research of Peritoneal Dialysis Solution with Dissolved Molecular Hydrogen[J]. Contributions to nephrology, 2018; 196: 162-70.
2. Nataatmadja MS, Johnson DW, Pascoe EM, et al. Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the balANZ Trial[J]. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2018, 38: 349-55.
3. Hamada C, Honda K, Kawanishi K, et al. Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution[J]. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2015, 18: 243-50.
4. del Peso G, Jimenez-Heffernan JA, Selgas R, et al. Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies[J]. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2016, 36: 129-34.
5. 王奕, 江薇, 刘峰, et al. 新型腹膜透析液影响患者临床预后的Meta分析[A]. 肾脏病与透析肾移植杂志, 2014, 23: 533-38+47.
6. Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis[A]. The Cochrane database of systematic reviews, 2018, 10: Cd007554.
7. Schaefer B, Bartosova M, Macher-Goeppinger S, et al. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis[J]. Kidney international, 2018, 94: 419-29.
8. Blake PG. Is the peritoneal dialysis biocompatibility hypothesis dead?[A]. Kidney international, 2018, 94: 246-48.
9. Olszowska A, Waniewski J, Stachowska-Pietka J, et al. Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport[J]. Frontiers in physiology, 2019, 10: 1326.
10. 张维. 比较艾考糊腹膜透析液与葡萄糖腹膜透析液对小分子溶质清除及糖脂代谢的meta分析[A]. 浙江大学, 2013.
11. Goossen K, Becker M, Marshall MR, et al. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials[A]. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020.
12. Kratochwill K, Boehm M, Herzog R, et al. Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids[J]. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, 27: 937-46.
13. Ferrantelli E, Liappas G, Vila Cuenca M, et al. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis[J]. Kidney international, 2016, 89: 625-35.
14. Kratochwill K, Boehm M, Herzog R, et al. Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial[J]. PloS one, 2016, 11: e0165045.
15. Vychytil A, Herzog R, Probst P, et al. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health[J]. Kidney international, 2018, 94: 1227-37.
16. Nishimura H, Ikehara O, Naito T, et al. Evaluation of taurine as an osmotic agent for peritoneal dialysis solution[J]. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2009, 29: 204-16.
17. La Han B, Guan Q, Chafeeva I, et al. Peritoneal and Systemic Responses of Obese Type II Diabetic Rats to Chronic Exposure to a Hyperbranched Polyglycerol-Based Dialysis Solution[J]. Basic & clinical pharmacology & toxicology, 2018, 123: 494-503.
18. Du C, Mendelson AA, Guan Q, et al. Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis[J]. Journal of translational medicine, 2016, 14: 338.
19. Rutkowski B, Tam P, van der Sande FM, et al. Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled Trial[J]. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, 67: 753-61.
20. Rutkowski B, Tam P, van der Sande FM, et al. Residual Renal Function and Effect of Low-Sodium Solution on Blood Pressure in Peritoneal Dialysis Patients[J]. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2019, 39: 335-43.